SLC5A2 and diabetes mellitus: The available oral drugs in clinical use for the treatment of diabetes include biguanides, sulfonylureas, insulin sensitizers, glinide insulin secretagogue, α-glucosidase inhibitors, dipeptidyl peptidase-IV (DPP-4) inhibitors, and sodium-glucose cotransporter 2 (SGLT-2) inhibitors [3].